Legal & Regulatory

Latest News

February 22nd 2009

The end or just the beginning? Exploring federal preemption of state marketing and distribution laws

By Sarina D. Rivera, Esq., Jennifer A. Sanfilippo, Esq., Porzio, Bromberg & Newman PC, Kiaema R. Reid, Porzio Pharmaceuitcal Services LLC

Multiplying state laws on marketing and distribution disclosures might be pre-empted by new federal legislation

February 22nd 2009

A REMS Will Be Part of the Expected Launch of Anti-Epilepsy Drug From Ovation Pharmaceuticals

Trending on Pharmaceutical Commerce

When Payers Know the Price of Everything

What the Independent Pharmacy Cooperative Acquisition of USave Pharmacy Group Signals

MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing

Beyond the Patent Cliff: Why Generics and Biosimilars Demand Different Playbooks

Inside the Three-Year Transition to NDC-12